Skip to main content
. 2021 Nov 16;10(22):5329. doi: 10.3390/jcm10225329

Figure 2.

Figure 2

Forest plots of hazard ratios of sarcopenia on overall survival in cancer patients treated with immune checkpoint inhibitors. (A) Overall survival in the univariate analysis. (B) Overall survival with adjusted HRs.